Your browser doesn't support javascript.
loading
Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys.
Kaul, S; Dandekar, K A.
Afiliação
  • Kaul S; Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Syracuse, New York 13221-4755.
Antimicrob Agents Chemother ; 37(5): 1160-2, 1993 May.
Article em En | MEDLINE | ID: mdl-8390811
Stavudine was administered (15 mg/kg of body weight) intravenously and orally to two monkeys in a randomized crossover study. Plasma and urine samples were analyzed for stavudine by high-performance liquid chromatography, and pharmacokinetic parameters were derived by a noncompartmental method. Total body clearance of stavudine was 0.64 liters/h/kg, with a steady-state volume of distribution of 0.68 liters/kg, a terminal half-life of 0.83 h, a urinary recovery of 44%, and an oral bioavailability of 80%. These values were reasonably similar to those reported for patients with AIDS or AIDS-related complex.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Didesoxinucleosídeos / HIV Tipo de estudo: Clinical_trials Limite: Animals / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 1993 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Didesoxinucleosídeos / HIV Tipo de estudo: Clinical_trials Limite: Animals / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 1993 Tipo de documento: Article País de publicação: Estados Unidos